Sanyuan Bio

What Sanyuan Bio does

Sanyuan Bio (山东三元生物科技股份有限公司) is a Chinese biotechnology manufacturer specializing in fermentation-based production of functional sugar substitutes. Founded in 2007 and headquartered in Binzhou, Shandong Province on a 330-acre industrial site, the company produces erythritol (135,000 tons annual capacity), D-allulose (10,000 tons, expanding to 20,000 tons), Rebaudioside M (>=95% purity), and compound sweetener blends. Its core technology is proprietary microbial fermentation with claimed high conversion rates and low energy consumption, backed by 31 national IP patents, 3 utility model patents, and an exclusive D-allulose enzyme arrangement with the CAS Tianjin Institute of Industrial Biotechnology. R&D is run through a Tianjin Free Trade Zone subsidiary ("Sanyuan Bioengineering Research (Tianjin) Co., Ltd.") integrating strain work, pilot testing, and industrialization.

The company operates a B2B ingredient model, selling sweetener inputs to food and beverage manufacturers, pharmaceutical companies, cosmetics/personal care brands, and health product companies. Domestically it runs two dedicated sales divisions managing accounts such as Jinmailang, Dali Foods, Heytea, and Perfect China. Internationally it holds self-operated import/export rights and distributes through partners including Faravelli (Italy), Prinova, and New Zealand International Chemical, reaching more than 40 countries with primary weighting toward Europe and the Americas. Certifications (ISO9001/14001/22000, BRC, FDA facility registration, KOSHER, HALAL, Non-GMO IP, SMETA) and four-ministry "National Key New Product" recognition are central to its enterprise customer-access moat.

Sanyuan Bio listed on the Shenzhen Stock Exchange ChiNext Board on February 10, 2022 (ticker 301206). Post-IPO it has been executing an aggressive capacity and portfolio expansion: a new erythritol line went into full operation in May 2023, a 50,000-ton erythritol project completed energy acceptance in July 2025, and a February 2025 RMB 200 million project converts a production line into an 85,000-ton flexible bio-synthetic platform capable of switching between erythritol, tagatose, mannitol, sorbitol, and steviol glycosides. Strategic positioning emphasizes synthetic biology, with chairman Nie Zaijian and chief scientist Ling Peixue publicly leading the company's industry positioning at SZSE and academic forums.

Name

Sanyuan Bio

Legal name

山东三元生物科技股份有限公司

Website

https://bzsanyuan.com

Company type

Public

Founded year

2007

Headcount range

51–100 employees

Short description

Sanyuan Bio is a Chinese fermentation biotech manufacturer of erythritol (135,000-ton capacity), D-allulose, Rebaudioside M, and compound sweeteners, supplying food and beverage, pharmaceutical, and cosmetics ingredient customers across 40+ countries via B2B sales and international distribution partners.

Ownership category

akta.pro rank

Product category

Functional Sweetener Ingredients

NAICS

Sugar and Confectionery Product Manufacturing (3113)

SIC

Sugar & Confectionery Products (2060)

akta.pro industry

PRIMARYCRADAOAB

Sweeteners (Sugar, HFCS, Alternative Sweeteners)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/CPG Ingredients, Flavorings & Additives Brands

SECONDARYAFAJAAAH

Natural High-Intensity Sweeteners (Stevia, Monk Fruit, Thaumatin)

Agriculture & Food Production/Food Ingredients & Additives/Sweeteners (Sugar, Syrups, High-Intensity Sweeteners)

SECONDARYAFAJAAAO

Sweetener Blends & Systems (Bulk + HIS Blends, Customized Sweetening Systems)

Agriculture & Food Production/Food Ingredients & Additives/Sweeteners (Sugar, Syrups, High-Intensity Sweeteners)

Keywords

• Fermented erythritol production
• Zero-calorie sweeteners
• D-allulose manufacturing
• Rebaudioside M stevia
• Compound sweetener blends

Headquarters

HQ city

Shandong

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Infrastructure, Technology or R&D, Operations, Personnel

Revenue model

1. Erythritol Sales: Primary revenue stream from erythritol production and sales. The company has annual production capacity of 135,000 tons of erythritol. Products are sold in various forms including different mesh sizes (20-30, 30-60, 60-80, 100 mesh) and packaging options.
2. Allulose (D-psicose) Sales: Revenue from allulose production with current capacity of 10,000 tons, with plans to expand to 20,000 tons in 2025. Available in both liquid and granular forms.
3. Rebaudioside M (Stevia) Sales: Sales of high-purity Rebaudioside M (>=95%) used in beverages, baking, dairy, pharmaceuticals, and personal care products.
4. Compound Sweetener Sales: Blended sweetener products combining erythritol with various high-intensity sweeteners (stevia, monk fruit extract, sucralose) and small packaging consumer products including table sweeteners and flavored solid beverages.
5. Export Sales: International sales through self-operated import/export rights, with primary markets in Europe and America, and distribution across East Asia, Southeast Asia, Australia/New Zealand, and over 40 countries/regions.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Sanyuan Bio manufactures zero- and low-calorie sweeteners using fermentation and synthetic biology methods, with a primary focus on erythritol (135,000 tons annual capacity) and D-allulose (10,000 tons, expanding to 20,000 tons in 2025). The company also produces Rebaudioside M stevia sweeteners and blended compound sweetener products for food, beverage, pharmaceutical, health product, and cosmetics manufacturers globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Erythritol (赤藓糖醇) Zero-calorie bulk sweetener produced via fermentation, available in multiple mesh sizes (20-30, 30-60, 60-80, 100 mesh) and packaging options. Annual production capacity of 135,000 tons. Used in food, beverages, baked goods, pharmaceuticals, and personal care products.
• D-Allulose (D-阿洛酮糖) Low-calorie sweetener with near-sucrose taste profile and energy of 1.67 kJ/g. Available in both liquid and granular forms. Current annual capacity of 10,000 tons, with plans to expand to 20,000 tons in 2025. Used in beverages, baking, dairy, and health products.
• Rebaudioside M (莱鲍迪苷M) High-purity stevia sweetener (>=95%) developed via synthetic biology, delivering 350x sucrose sweetness without the aftertaste of ordinary stevia glycosides. Used in beverages, baking, dairy, pharmaceuticals, and personal care products.
• Compound Sweeteners (复配糖) Blended sweetener products combining erythritol with various high-intensity sweeteners including stevia, monk fruit extract (罗汉果甜苷), and sucralose. Custom formulations available. Used in beverages, baked goods, and tabletop sweeteners.
• Small Package Consumer Sweeteners (小包装) Retail-sized erythritol and table sweetener products, including erythritol 500g bags and compound table sweeteners in 150g, 1kg bags, and 1.5kg gift boxes. Targeted at consumer end-users.

Quantifiable outcome

• Rebaudioside M sweetness reaches 350x sucrose with no aftertaste
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators7 records

Recent moves11 records

Expansion highlights3 records

Broad incumbents

• ADM: Global agricultural processor with broad sweetener and natural-ingredient product lines; competes in food and beverage ingredient supply at scale across multiple geographies.
• Tate & Lyle: Established sweetener and food-ingredient producer with Splenda (sucralose) and stevia platforms plus specialty corn-derived ingredients; competes in zero/low-calorie sweetener B2B ingredient supply to global CPGs.
• Roquette: French starch- and polyol-derived ingredient manufacturer producing erythritol, sorbitol, mannitol, and specialty starches for food, nutrition, and pharma — directly competes in erythritol and rare-sugar polyols for B2B customers.
• Kerry Group: Global taste and nutrition ingredients company with a sweetener portfolio serving food and beverage manufacturers — comparable as a scaled B2B ingredient supplier across multiple sweetener categories.
• Cargill: Global food-ingredients incumbent offering erythritol, stevia, and other sweeteners across food, beverage, and nutrition categories — competes head-to-head in bulk sweetener supply with broader portfolio and Western distribution.
• Ingredion (incl. PureCircle): Global ingredient solutions provider with the PureCircle stevia franchise; competes in the same B2B high-intensity sweetener supply channel with extensive Western CPG distribution.

Direct peers

• Shandong Fuyang Biotechnology: Direct Chinese competitor producing D-allulose and fermentation-based functional sugars; shares the same synthetic biology approach, allulose enzyme IP origin (CAS Tianjin Institute), and B2B sweetener ingredient model targeting food and beverage manufacturers.
• SweeGen: Specialist producer of high-purity stevia Rebaudioside M and other steviol glycosides — directly competes with Sanyuan Bio's Reb M offering targeting beverage, dairy, and food manufacturers.

Emerging players

• Bonumose: US-based specialist in enzymatic production of rare sugars including D-allulose and tagatose — direct competitor in next-generation rare-sugar fermentation that overlaps with Sanyuan Bio's allulose/tagatose pipeline.

Regional players

• Zhucheng Haotian Pharmaceutical: Chinese fermentation-based ingredient and pharmaceutical-intermediate producer with adjacent stevia and functional sugar programs — comparable to Sanyuan Bio as a domestic Chinese competitor in fermentation-derived functional sweeteners.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/shandong-sanyuan-biotechnology-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanyuan Bio